The Federal Trade Commission (FTC) also enforces technology violations as they relate to consumers under the Federal Trade Commission Act. In December 2023, the FTC banned Rite Aid from using artificial intelligence “facial recognition technology for surveillance purposes for five years to settle [FTC] charges that the retailer failed to implement reasonable procedures and prevent harm to consumers in its use of facial recognition technology in hundreds of stores.” Notably,
The proposed order will require Rite Aid to implement comprehensive safeguards to prevent these types of harm to consumers when deploying automated systems that use biometric information to track them or flag them as security risks. It also will require Rite Aid to discontinue using any such technology if it cannot control potential risks to consumers. To settle charges it violated a 2010 Commission data security order by failing to adequately oversee its service providers, Rite Aid will also be required to implement a robust information security program, which must be overseen by the company’s top executives.
States are also enforcing privacy violations related to biometric data. For example, in July 2024, Texas Attorney General Ken Paxton, through the Texas Deceptive Trade Practices Act coupled with violations of Texas’ biometric laws, settled with Meta f/k/a Facebook for $1.4 billion “to stop the company’s practice of capturing and using the personal biometric data of millions of Texans without the authorization required by law.”
Companies can face a myriad of enforcement actions, as well as class action lawsuits. The best ways to stave off litigation are to have an effective compliance program, board governance, and comply with HIPAA and state laws.
Rachel V. Rose, JD, MBA, advises clients on compliance, transactions, government administrative actions, and litigation involving healthcare, cybersecurity, corporate and securities law, as well as False Claims Act and Dodd-Frank whistleblower cases. She also teaches bioethics at Baylor College of Medicine in Houston. Rachel can be reached through her website, www.rvrose.com.